Invitation to presentation of the Q2 report 2024

Oncopeptides AB will publish the report for the second quarter of 2024, at 08:00 CET on August 14, 2024. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session, at 09:00 CET the same day.

The presentation will be hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. The webcast will be held in English and published below in conjunction with the start of the presentation.

Information for participants

If you wish to participate via webcast, please use the link below.
https://ir.financialhearings.com/oncopeptides-q2-report-2024

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://conference.financialhearings.com/teleconference/?id=50048826

For more information, please contact:

David Augustsson, Director of IR and Communications, Oncopeptides AB
E-mail: david.augustsson@oncopeptides.com
Cell phone: +46 76 229 38 68